VIVO BIO TECH LTD. (VIVOBIOT)

BSE: ₹24.04
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper advertisement - Notice of postal ballot & e-voting

2026-06-13 14:12:50
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Please find enclosed Postal Ballot Notice

2026-06-12 11:16:42
Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper publication of notice for special window for re-lodgement of transfer request of physical shares

2026-06-09 12:17:33
Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper publication for the Audited Financial Results for the Quarter and Year ended March 31, 2026.

2026-06-02 11:22:57
Board Meeting Outcome for Outcome Of The Board Meeting

please find enclosed outcome of the Board Meeting

2026-05-30 19:49:05
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Which Is Scheduled To Be Held On Friday, May 29, 2026 Is Postponed And Will Be Held On Saturday, May 30, 2026.

1. To consider and approve the Audited Standalone & Consolidated Financial Results of the Company for the Fourth Quarter and Year ended March 31, 2026. 2. To consider and approve the amalgamation of M/s. Shri Shri Resorts Private Limited (Transferor Company) with and into M/s. Vivo Bio Tech Limited (Transferee Company) under Sections 230 to 232 and other relevant provisions of the Companies Act, 2013, SEBI Listing Regulations etc.

2026-05-29 21:47:59

Quarterly Financials

Consolidated Standalone
Particulars Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Revenue from Operations 9.26 12.85 11.76 10.13 12.04 12.21 12.29 12.51 13.11 13.51 14.20 14.28
YOY Revenue Growth % -26.91% -5.08% -20.33% -12.5% 29.94% -4.95% 4.53% 23.46% 8.92% 10.65% 15.54% 14.13%
Other Income 0.00 0.03 0.01 0.01 4.63 0.01 0.15 0.14 0.13 0.14 0.03 0.06
Total Income 9.26 12.88 11.77 10.15 16.67 12.22 12.44 12.65 13.24 13.65 14.23 14.34
Total Expenses + 8.80 10.97 10.33 9.92 10.80 10.76 11.20 11.17 11.73 12.08 13.38 14.00
Cost of Materials Consumed 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.01
Employee Benefit Expense 2.03 2.95 2.68 2.34 3.44 3.22 3.14 3.20 4.08 4.33 4.88 4.73
Other Expenses 2.27 2.54 2.69 1.75 1.52 1.59 3.36 2.31 1.52 1.53 1.90 2.64
Operating Profit 0.46 1.88 1.43 0.21 1.24 1.45 1.09 1.34 1.38 1.43 0.83 0.28
OPM % 5% 14.6% 12.1% 2.1% 10.3% 11.9% 8.9% 10.7% 10.5% 10.6% 5.8% 2%
Profit Before Tax + 0.46 1.91 1.43 0.22 5.87 1.46 1.24 1.48 1.51 1.57 0.25 0.34
Tax Expense 0.14 0.59 0.70 0.06 0.63 0.64 0.18 0.14 0.64 0.32 5.41 0.15
Tax % 29.6% 30.8% 48.7% 25.3% 10.8% 43.9% 14.4% 9.6% 42.4% 20.5% 2156.9% 44.6%
Profit After Tax 0.33 1.32 0.74 0.17 5.23 0.82 1.06 1.34 0.87 1.25 -5.16 0.19
EPS (Basic) 0.22 0.89 0.50 0.11 3.51 0.55 0.69 0.74 0.45 0.56 -2.52 0.08

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 53.33 46.67 45.45 52.23 51.39 51.78
YOY Revenue Growth % 14.27% 2.69% -12.98% 1.63% -0.74% -
Other Income 0.44 4.80 0.04 0.04 0.10 0.08
Total Income 53.78 51.48 45.49 52.27 51.49 51.85
Total Expenses + 48.36 42.68 41.43 47.65 47.02 43.23
Employee Benefit Expense 16.49 12.14 10.68 13.52 9.42 8.57
Other Expenses 7.27 8.23 9.83 10.43 14.72 18.34
Operating Profit 4.97 3.99 4.02 4.58 4.37 8.54
OPM % 9.3% 8.5% 8.8% 8.8% 8.5% 16.5%
Profit Before Exceptional 5.41 8.79 4.06 4.62 4.47 8.62
Exceptional Items -0.60 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 4.81 8.79 4.06 4.62 4.47 8.62
Tax Expense 6.52 1.51 1.53 1.97 2.27 2.94
Tax % 135.5% 17.2% 37.8% 42.7% 50.8% 34.1%
Profit After Tax -1.71 7.28 2.53 2.65 2.20 5.68
EPS (Basic) -0.82 4.76 1.70 1.78 1.56 4.23

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 150.02 101.29 89.90 91.24 96.45 52.44
Property, Plant & Equipment 71.80 64.38 72.25 78.07 81.55 40.71
Capital Work in Progress 4.81 12.84 9.21 1.90 0.87 0.32
Non-Current Investments 21.91 0.00 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 51.23 23.86 8.12 10.81 13.62 11.34
Current Assets + 28.42 41.94 47.23 31.79 26.03 27.09
Inventories 8.15 7.79 8.77 7.97 9.81 13.28
Trade Receivables 11.75 11.25 11.80 12.38 12.02 7.29
Cash and Cash Equivalents 1.44 1.28 1.39 1.37 1.71 1.17
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 93.16 77.90 54.40 51.87 45.95 42.53
Equity Share Capital 22.19 17.16 14.90 14.90 14.26 13.42
Other Equity 70.97 60.74 39.50 36.97 31.68 29.11
Non-Current Liabilities 55.04 37.49 44.82 46.19 52.18 15.16
Current Liabilities 30.23 27.84 37.91 24.97 24.36 21.84
Total Liabilities 85.27 65.33 82.73 71.16 76.54 37.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities 34.93 11.83 15.52 7.37 15.01 14.18
Cash from Investing Activities -59.35 -15.84 -7.95 -4.00 -51.11 -22.82
Cash from Financing Activities 24.57 3.90 -7.56 -3.71 36.65 8.78
Net Increase/Decrease in Cash 0.15 -0.11 0.01 -0.34 0.55 0.14